(Reuters) - Canadian drug developer Medicago said on Tuesday it had started a late-stage study of its experimental COVID-19 vaccine combined with an adjuvant from GlaxoSmithKline. Sign up here. The ...
A plant-based vaccine producer will lay off 60 people at its Research Triangle Park office, a new filing shows. On Wednesday, the Canadian company Medicago sent a WARN notice to the N.C. Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results